XML 45 R32.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF SHARE-BASED COMPENSATION EXPENSE

The following table summarizes the amount of share-based compensation expense by line item on the condensed consolidated statements of operations:

 

(in thousands)  2025   2024   2025   2024 
Share-based compensation expense  Three Months Ended   Six Months Ended 
   June 30,   June 30, 
(in thousands)  2025   2024   2025   2024 
Research and development expense  $521   $1,252   $1,029   $2,596 
Sales, marketing, general and administrative expense   1,409    2,101    2,822    4,500 
Total Share-based compensation expense  $1,930   $3,353   $3,851   $7,096 
SCHEDULE OF OPTIONS ACTIVITY AND POSITIONS

The following table summarizes shares, weighted-average exercise price, weighted-average remaining contractual term, and aggregate intrinsic value of options outstanding and options exercisable as of June 30, 2025 (in thousands, except per share data):

  

           Weighted-     
       Weighted-   Average     
       Average   Remaining   Aggregate 
Options      Exercise   Contractual   Intrinsic 
   Shares   Price   Term (years)   Value 
Outstanding as of June 30, 2025   666   $1.43        3.0   $129 
                     
Exercisable as of June 30, 2025   666   $1.43    3.0   $129 
SCHEDULE OF ACTIVITY AND POSITIONS WITH RESPECT TO RSUs AND PSUs

The following table summarizes activity and positions with respect to RSUs and PSUs for the six months ended June 30, 2025 (in thousands, except per share data):

 

       Weighted-Average 
   Shares   Price 
Unvested as of December 31, 2024 ¹   12,913   $1.53 
Granted   10,568    1.15 
Vested   (1,681)   1.95 
Forfeited   (577)   1.74 
Unvested as of June 30, 2025   21,223   $1.30 

 

1The number of unvested RSUs and PSUs and the weighted-average price as of December 31, 2024 reported in this Note has been adjusted to 12,913 from 12,013 and to $1.53 from $1.51, respectively, as reported in Note 9 of the Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, due to the correction of an administrative error. The correction resulted in no change to the previously issued financial statements and the Company deems the administrative error not material from a quantitative or qualitative perspective.